These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1682 related items for PubMed ID: 12777588

  • 1. Substance use problems and associated psychiatric symptoms among adolescents in primary care.
    Shrier LA, Harris SK, Kurland M, Knight JR.
    Pediatrics; 2003 Jun; 111(6 Pt 1):e699-705. PubMed ID: 12777588
    [Abstract] [Full Text] [Related]

  • 2. Comorbid mental disorders in substance users from a single catchment area--a clinical study.
    Langås AM, Malt UF, Opjordsmoen S.
    BMC Psychiatry; 2011 Feb 12; 11():25. PubMed ID: 21314980
    [Abstract] [Full Text] [Related]

  • 3. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF, Miller A, Fine S.
    Pediatrics; 2004 Nov 12; 114(5):e541-7. PubMed ID: 15520087
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Attention Deficit Hyperactivity Disorder (ADHD) Subtypes, Co-Occurring Psychiatric Symptoms and Sexual Risk Behaviors among Adolescents Receiving Substance Abuse Treatment.
    Regan T, Tubman J.
    Subst Use Misuse; 2020 Nov 12; 55(1):119-132. PubMed ID: 31502500
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Temporal association of onset of daily smoking with adolescent substance use and psychiatric morbidity.
    Ilomäki R, Riala K, Hakko H, Lappalainen J, Ollinen T, Räsänen P, Timonen M, Study 70 Workgroup.
    Eur Psychiatry; 2008 Mar 12; 23(2):85-91. PubMed ID: 18082380
    [Abstract] [Full Text] [Related]

  • 11. Comorbidity of substance use disorders and other psychiatric disorders among adolescents: evidence from an epidemiologic survey.
    Roberts RE, Roberts CR, Xing Y.
    Drug Alcohol Depend; 2007 Apr 12; 88 Suppl 1(Suppl 1):S4-13. PubMed ID: 17275212
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Substance use disorders in individuals with body dysmorphic disorder.
    Grant JE, Menard W, Pagano ME, Fay C, Phillips KA.
    J Clin Psychiatry; 2005 Mar 12; 66(3):309-16; quiz 404-5. PubMed ID: 15766296
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Attention Deficit Hyperactivity Disorder in Prisoners: Increased Substance Use Disorder Severity and Psychiatric Comorbidity.
    Vélez-Pastrana MC, González RA, Ramos-Fernández A, Ramírez Padilla RR, Levin FR, Albizu García C.
    Eur Addict Res; 2020 Mar 12; 26(4-5):179-190. PubMed ID: 32615575
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical prevalence and correlates of substance use in adolescent psychiatric emergency patients.
    McDonell MG, Hsiao RC, Russo J, Pasic J, Ries RK.
    Pediatr Emerg Care; 2011 May 12; 27(5):384-9. PubMed ID: 21494164
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adolescent substance abuse and psychiatric comorbidities.
    Deas D.
    J Clin Psychiatry; 2006 May 12; 67 Suppl 7():18-23. PubMed ID: 16961420
    [Abstract] [Full Text] [Related]

  • 20. Comorbidity of migraine and psychiatric disorders among substance-dependent inpatients.
    McDermott MJ, Tull MT, Gratz KL, Houle TT, Smitherman TA.
    Headache; 2014 Feb 12; 54(2):290-302. PubMed ID: 23848988
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 85.